3/10/2024 0 Comments Dr steven schwartz retina![]() The uveitis session was moderated by Sunil Srivastava, MD, and included Emmett Cunningham, MD, PhD, MPH Quan Nguyen, MD, MSc and University of California Los Angeles’ very own Dr. Sadda and Sarraf presented their work regarding OCT biomarkers for progression of intermediate AMD and non-neovascular fluid in AMD, respectively. Jumper, provided attendees with the latest on difficult pediatric retina cases and choices regarding prophylactic barrier laser in Stickler syndrome. The pediatric surgery panel, moderated by Dr. Duker led into an illuminating debate regarding a series of cases with subtle OCT findings. Richard Spaide, MD, bookended the imaging session with amazing new OCT and 3D images of the vitreous. Fawzi, MD, kicked off a star-studded panel on retinal imaging with her presentation, “Predicting progression of diabetic retinopathy in OCTA.” This was followed by a fascinating talk by David Brown, MD, who discussed increased choroidal thickness seen in NASA astronauts during spaceflight. Mieler, MD, was similarly engaging, and Amani A. The tumor panel that followed, moderated by William F. McDonald cried out, “Correct!” and proceeded to the next image. The cases were presented in a rapid-fire style, with some panelists only having time to answer with a quick sentence or two before Dr. Michael Jumper, MD Colin McCannel, MD Gaurav K. McDonald leading an action-packed surgical panel, which included J. Curcio, PhD, touched on progression modeling of hyperreflective foci in AMD. Nadia Waheed, MD, MPH, discussed progression modeling of geographic atrophy, while Christine A. ![]() Sadda led things off by moderating a host of basic science lectures. The second day of the conference started with no less energy than the first. ![]() Duker, MD, who discussed the past, present, and future of OCT. The highlight of the day was the Alexander R. The session concluded with a presentation on the importance of using automatically segmented maps to highlight ganglion cell layer loss. He finally revealed that it was caused by ingestion of potassium iodide pills-used to protect the thyroid from radioactive iodine in the event of a nuclear emergency. The audience and panelists were stumped by a case, presented by Paul Bernstein, MD, PhD, of diffuse retinal pigment epithelial atrophy. Boyer, MD, discussed a case of sterile endophthalmitis that cropped up after switching from prefilled syringes to vials he noted the decreasing frequency of endophthalmitis with prefilled syringes compared with vial injections. The trainee session was capped by a debate about whether a patient’s choroidal thickness changes were due to uveitis from a herpetic infection or steroid administration. The audience was captivated by the range of infectious cases, such as a case of tuberculosis that took an unusual turn with an ovarian mass. ![]() Phototoxicity and toxicity from anastrozole, didanosine (Videx, Bristol-Myers Squibb), pentosan polysulfate sodium (Elmiron, Janssen Pharmaceuticals), deferoxamine (Desferal, Novartis), and latanoprost were discussed. Medical students, residents, and fellows presented first with mystery cases, but it proved difficult to trick the panelists. Held at the University of California Los Angeles on April 1-2, the event was no joke, kicking off with more than 50 clinical case presentations that kept the audience on its toes with discussions of genetic, infectious, inflammatory, and toxic cases. Pictured here are (left to right): Jean-Pierre Hubschman, MD Carl D. The conference organizers were honored to be joined by many colleagues to help them provide exceptional education. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |